Black Diamond Therapeutics Inc (BDTX)
1.5700 x 1 1.6400 x 21
Post-market by (Cboe BZX)
1.6000 +0.0100 (+0.63%) 04/28/25 [NASDAQ]
1.5700 x 1 1.6400 x 21
Post-market 1.6000 unch (unch) 19:19 ET
for Mon, Apr 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -69,676 | -82,442 | -91,169 | -125,596 | -67,254 |
| Depreciation Amortization | 343 | 437 | 508 | 205 | 52 |
| Accounts payable and accrued liabilities | 1,683 | 597 | -2,230 | 1,569 | 1,069 |
| Other Working Capital | -2,692 | 3,686 | -9,901 | 7,020 | 5,042 |
| Other Operating Activity | 8,039 | 11,005 | 17,710 | 16,654 | 8,945 |
| Operating Cash Flow | $-62,303 | $-66,717 | $-85,082 | $-100,148 | $-52,146 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 94 | 62 | -183 | -2,710 | -142 |
| Purchase Of Investment | -122,876 | -61,887 | -60,141 | -49,508 | -372,477 |
| Sale Of Investment | 139,750 | 78,171 | 113,690 | 182,831 | 90,928 |
| Investing Cash Flow | $16,968 | $16,346 | $53,366 | $130,613 | $-281,691 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 25,547 | 71,932 | 177 | 729 | 214,944 |
| Financing Cash Flow | $25,547 | $71,932 | $177 | $729 | $214,944 |
| Beginning Cash Position | 57,044 | 35,483 | 67,022 | 35,828 | 154,721 |
| End Cash Position | 37,256 | 57,044 | 35,483 | 67,022 | 35,828 |
| Net Cash Flow | $-19,788 | $21,561 | $-31,539 | $31,194 | $-118,893 |
| Free Cash Flow | |||||
| Operating Cash Flow | -62,303 | -66,717 | -85,082 | -100,148 | -52,146 |
| Capital Expenditure | 0 | -33 | -192 | -2,710 | -142 |
| Free Cash Flow | -62,303 | -66,750 | -85,274 | -102,858 | -52,288 |